Enhanced activation of STAT3 in ascites-derived recurrent ovarian tumors: inhibition of cisplatin-induced STAT3 activation reduced tumorigenicity of ovarian cancer by a loss of cancer stem cell-like characteristics
Journal of Cancer Stem Cell Research 2015, 3e1001 (February 27, 2015)
